---
title: Building the Future Management of Follicular Lymphoma with T-Cell-Redirecting
  Strategies
date: '2024-11-14'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39541577/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20241115181608&v=2.18.0.post9+e462414
source: Blood
description: Follicular lymphoma (FL) usually requires multiple lines of therapy and
  disease control remains largely insufficient with conventional chemoimmunotherapy.
  Several T-cell redirecting strategies recently approved in the relapsed/refractory
  setting have the potential to improve outcomes and change the treatment algorithm
  in FL. This review focuses on the role of chimeric antigen receptor T-cells and
  bispecific antibodies in FL, paying special attention to sequencing approaches and
  ...
disable_comments: true
---
Follicular lymphoma (FL) usually requires multiple lines of therapy and disease control remains largely insufficient with conventional chemoimmunotherapy. Several T-cell redirecting strategies recently approved in the relapsed/refractory setting have the potential to improve outcomes and change the treatment algorithm in FL. This review focuses on the role of chimeric antigen receptor T-cells and bispecific antibodies in FL, paying special attention to sequencing approaches and ...